Optimizing cationic and neutral lipids for efficient gene delivery at high serum content.

Area of Science:

• Biotechnology
• Gene Therapy
• Nanomedicine

Background:

• Cationic liposome (CL)-DNA complexes are key gene delivery vectors.
• Serum negatively impacts transfection efficiency (TE), limiting in vivo applications.
• Understanding high serum effects on TE is crucial for optimizing CL-DNA complexes.

Purpose of the Study:

• To investigate the impact of serum content on the TE of CL-DNA complexes.
• To identify optimal formulations of CL-DNA complexes with enhanced serum resistance.
• To provide design guidelines for in vivo gene therapy applications.

Main Methods:

• Prepared CL-DNA complexes varying neutral lipids, cationic lipid headgroups, and lipid ratios.
• Measured TE as a function of serum content (up to 50%).
• Assessed cytotoxicity and tested formulations in human cancer cell lines (M21/melanoma, PC-3/prostate).

Main Results:

• All tested CL-DNA complexes showed high TE in the absence of serum.
• Specific multivalent lipid and neutral lipid combinations (e.g., MVL5(5+)/GMO-DNA) maintained high TE in serum.
• Optimized complexes matched or exceeded benchmark reagents' TE, especially at high serum concentrations.

Conclusions:

• Two-component CL-DNA vectors can achieve superior gene delivery efficiency compared to benchmarks, even with up to 50% serum.
• Developed guidelines for enhancing serum resistance in CL-DNA complexes.
• These findings pave the way for more effective in vivo gene therapy strategies.